FindTrial
Sign In

Vasopressor drugs in regional anaesthesia for obstetrics: Quantification of transplacental transfer and determination of metabolic effects on the fetus

Vasopressor drugs in regional anaesthesia for obstetrics: Quantification of transplacental transfer and determination of metabolic effects on the fetus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000662
Enrollment
Unknown
Registered
2005-09-22
Start date
2005-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conditions of the Urinary Tract and Sexual Organs, and Pregnancy

Interventions

Two groups:Vasopressor drugs: ephedrine, phenylephrine Approx 30 minutes

Sponsors

Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion: term healthy parturients having elective caesarean section under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: Exclusion: fetal abnormality, hypertension, preeclampsia

Design outcomes

Primary

MeasureTime frame
Umbilical artery pH;—

Secondary

MeasureTime frame
Maternal and placental drug levels and biochemical markers.;—

Countries

China

Contacts

Public ContactProfessor W. Ngan Kee
warwick@cuhk.edu.hk+852 26322735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026